Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Other financing activities (2019 - 2026)

Kodiak Sciences' (KOD) quarterly Other financing activities came in at $922000.0 in Q1 2026, up 643.55% YoY from $124000.0 in Q1 2025, and down 99.47% on a QoQ basis from $172.9 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Other financing activities (2019 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 8 years of Other financing activities data on file, last reported at $922000.0 in Q1 2026.

  • Quarterly Other financing activities rose 643.55% year-over-year to $922000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173.8 million (up 89930.05% YoY) and the FY2025 annual result came in at $173.0 million, up 161544.86% from the prior year.
  • Other financing activities slipped to $922000.0 in Q1 2026, from $172.9 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $172.9 million in Q4 2025 to a low of -$1.6 million in Q2 2022.
  • A 5-year average of $12.6 million and a median of $85000.0 in 2023 frame the typical range for Other financing activities.
  • Annual changes were most pronounced in 2023 — Other financing activities plunged 104.16% — and 2025, when it soared 360062.5%.
  • Tracing KOD's Other financing activities over 5 years: stood at $1.7 million in 2022, then tumbled by 92.85% to $122000.0 in 2023, then slumped by 60.66% to $48000.0 in 2024, then soared by 360062.5% to $172.9 million in 2025, then plunged by 99.47% to $922000.0 in 2026.
  • The last three Other financing activities figures came in at $922000.0 (Q1 2026), $172.9 million (Q4 2025), and -$42000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Mar 31, 2026 922,000.00
Dec 31, 2025 172.03 Mn
Sep 30, 2025 813,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 124,000.00
Dec 31, 2024 335,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 38,000.00
Dec 31, 2023 51,000.00
Jun 30, 2023 122,000.00
Mar 31, 2023 9,000.00
Sep 30, 2022 90,000.00
Jun 30, 2022 2,000.00
Mar 31, 2022 1.68 Mn
Dec 31, 2021 1.99 Mn
Sep 30, 2021 2.04 Mn
Jun 30, 2021 2.23 Mn
Mar 31, 2021 1.48 Mn
Mar 31, 2020 99.64 Mn